BACKGROUND: Heterotopic ossification (HO) affects the majority of combat-related lower extremity wounds involving severe fracture and amputation. Defining the timing of early osteogenic-related genes may help identify candidate prophylactic agents and guide the timing of prophylactic therapy after blast and other combat-related extremity injuries. QUESTIONS/PURPOSES: Using a recently developed animal model of combat-related HO, we sought to determine (1) the timing of early chondrogenesis, cartilage formation, and radiographic ectopic bone development; and (2) the early cartilage and bone-related gene and protein patterns in traumatized soft tissue. METHODS: We used an established rat HO model consisting of blast exposure, controlled femur fracture, crush injury, and transfemoral amputation through the zone of injury. Postoperatively, rats were euthanized on Days 3 to 28. We assessed evidence of early ectopic bone formation by micro-CT and histology and performed proteomic and gene expression analysis. RESULTS: All rats showed radiographic evidence of HO within 28 days. Key chondrogenic (collagen type I alpha 1 [COL1α1], p = 0.016) and osteogenic-related genes (Runt-related transcription factor 2 [RUNX-2], p = 0.029; osteoclacin [OCN], p = 0.032; phosphate-regulating neutral endopeptidase, X-linked [PHEX], p = 0.0290, and POU domain class 5 transcription factor [POU5F], p = 0.016) and proteins (Noggin [NOG], p = 0.04, OCN, p = 0.02, RUNX- 2, p = 0.04, and substance P-1 [SP-1], p = 0.01) in the injured soft tissue, normalized to the contralateral limb and/or sham-treated naïve rats, increased on Days 3 to 14 postinjury. By 14 days, foci of hypertrophic chondrocytes, hyaline cartilage, and woven bone were present in the soft tissue surrounding the amputation site. CONCLUSIONS: We found that genes that regulate early chondrogenic and osteogenic signaling and bone development (COL1α1, RUNX-2, OCN, PHEX, and POU5F1) are induced early during the tissue reparative/healing phase in a rat model simulating a combat-related extremity injury. CLINICAL RELEVANCE: The ability to correlate molecular events with histologic and morphologic changes will assist researchers and clinicians to understand HO and hence formulate therapeutic interventions.
BACKGROUND: Heterotopic ossification (HO) affects the majority of combat-related lower extremity wounds involving severe fracture and amputation. Defining the timing of early osteogenic-related genes may help identify candidate prophylactic agents and guide the timing of prophylactic therapy after blast and other combat-related extremity injuries. QUESTIONS/PURPOSES: Using a recently developed animal model of combat-related HO, we sought to determine (1) the timing of early chondrogenesis, cartilage formation, and radiographic ectopic bone development; and (2) the early cartilage and bone-related gene and protein patterns in traumatized soft tissue. METHODS: We used an established rat HO model consisting of blast exposure, controlled femur fracture, crush injury, and transfemoral amputation through the zone of injury. Postoperatively, rats were euthanized on Days 3 to 28. We assessed evidence of early ectopic bone formation by micro-CT and histology and performed proteomic and gene expression analysis. RESULTS: All rats showed radiographic evidence of HO within 28 days. Key chondrogenic (collagen type I alpha 1 [COL1α1], p = 0.016) and osteogenic-related genes (Runt-related transcription factor 2 [RUNX-2], p = 0.029; osteoclacin [OCN], p = 0.032; phosphate-regulating neutral endopeptidase, X-linked [PHEX], p = 0.0290, and POU domain class 5 transcription factor [POU5F], p = 0.016) and proteins (Noggin [NOG], p = 0.04, OCN, p = 0.02, RUNX- 2, p = 0.04, and substance P-1 [SP-1], p = 0.01) in the injured soft tissue, normalized to the contralateral limb and/or sham-treated naïve rats, increased on Days 3 to 14 postinjury. By 14 days, foci of hypertrophic chondrocytes, hyaline cartilage, and woven bone were present in the soft tissue surrounding the amputation site. CONCLUSIONS: We found that genes that regulate early chondrogenic and osteogenic signaling and bone development (COL1α1, RUNX-2, OCN, PHEX, and POU5F1) are induced early during the tissue reparative/healing phase in a rat model simulating a combat-related extremity injury. CLINICAL RELEVANCE: The ability to correlate molecular events with histologic and morphologic changes will assist researchers and clinicians to understand HO and hence formulate therapeutic interventions.
Authors: Benjamin K Potter; Jonathan A Forsberg; Thomas A Davis; Korboi N Evans; Jason S Hawksworth; Doug Tadaki; Trevor S Brown; Nicole J Crane; Travis C Burns; Frederick P O'Brien; Eric A Elster Journal: J Bone Joint Surg Am Date: 2010-12 Impact factor: 5.284
Authors: E M Polfer; D N Hope; E A Elster; A T Qureshi; T A Davis; D Golden; B K Potter; J A Forsberg Journal: Bone Joint J Date: 2015-04 Impact factor: 5.082
Authors: Jonathan Agner Forsberg; Joseph M Pepek; Scott Wagner; Kevin Wilson; James Flint; Romney C Andersen; Doug Tadaki; Frederick A Gage; Alexander Stojadinovic; Eric A Elster Journal: J Bone Joint Surg Am Date: 2009-05 Impact factor: 5.284
Authors: Amy L Strong; Philip J Spreadborough; Chase A Pagani; Ryan M Haskins; Devaveena Dey; Patrick D Grimm; Keiko Kaneko; Simone Marini; Amanda K Huber; Charles Hwang; Kenneth Westover; Yuji Mishina; Matthew J Bradley; Benjamin Levi; Thomas A Davis Journal: Bone Date: 2020-07-02 Impact factor: 4.398
Authors: Alexandra Stanley; Su-Jin Heo; Robert L Mauck; Foteini Mourkioti; Eileen M Shore Journal: J Bone Miner Res Date: 2019-08-19 Impact factor: 6.741
Authors: Gabriel J Pavey; Ammar T Qureshi; Allison M Tomasino; Cary L Honnold; Danett K Bishop; Shailesh Agarwal; Shawn Loder; Benjamin Levi; Maurizio Pacifici; Masahiro Iwamoto; Benjamin K Potter; Thomas A Davis; Jonathan A Forsberg Journal: Bone Date: 2016-06-28 Impact factor: 4.398
Authors: Ammar T Qureshi; Devaveena Dey; Erin M Sanders; Jonathan G Seavey; Allison M Tomasino; Kaitlyn Moss; Benjamin Wheatley; David Cholok; Shawn Loder; John Li; Benjamin Levi; Thomas A Davis Journal: Am J Pathol Date: 2017-10-10 Impact factor: 4.307
Authors: Nicole J Edwards; Eric Hobson; Devaveena Dey; Alisha Rhodes; Archie Overmann; Benjamin Hoyt; Sarah A Walsh; Chase A Pagani; Amy L Strong; Geoffrey E Hespe; Karthik R Padmanabhan; Amanda Huber; Cheri Deng; Thomas A Davis; Benjamin Levi Journal: Stem Cells Dev Date: 2021-04-19 Impact factor: 3.272
Authors: Amy L Strong; Philip J Spreadborough; Devaveena Dey; Peiran Yang; Shuli Li; Arthur Lee; Ryan M Haskins; Patrick D Grimm; Ravi Kumar; Matthew J Bradley; Paul B Yu; Benjamin Levi; Thomas A Davis Journal: Stem Cells Dev Date: 2020-12-24 Impact factor: 3.272
Authors: Shailesh Agarwal; James Drake; Ammar T Qureshi; Shawn Loder; Shuli Li; Kay Shigemori; Jonathan Peterson; David Cholok; Jonathan A Forsberg; Yuji Mishina; Thomas A Davis; Benjamin Levi Journal: PLoS One Date: 2016-08-05 Impact factor: 3.240